Zn is an inhibitor of mitochondrial aconitase in the prostate, so malignant prostatic cells, which have lost the ability to accumulate Zn, switch from citrate-producing cells into citrate-oxidizing ones, thus satisfying the increased energy demands for cancer cells [28]. The gene discussed is ACO2; the disease is cancer.